ResistanceBio
PrivateLast Round
Series A
Jan 31, 2024
Est. Valuation
$2.14M
Total Funding Raised
$18.55M
Company Overview
ResistanceBio operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a Series A round in January 2024.
ResistanceBio is a biotechnology company that develops therapeutics and predictive models to combat treatment-resistant cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ResistanceBio Comparables
Compare ResistanceBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Red Queen Bio | 82% | |
| Alixia | 81% | |
| Synamics Therapeutics | 79% |
For institutional investors. Book with your work email.
ResistanceBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 31, 2024 | ||||
| Seed | Mar 29, 2021 | ||||
| Accelerator | Mar 1, 2019 | ||||
| Grant | Sep 11, 2017 |
For institutional investors. Book with your work email.
ResistanceBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centennial Investors | Series A |
| NFX | Series A, Seed |
| Cantos Ventures | Series A |
| Awah Ventures | Series A |
| Brightstone Venture Capital | Series A |
| Y Combinator | Series A, Seed, Accelerator |
| Liquid 2 Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 31, 2024
$13M round with participation from NFX and Alumni Ventures.
- Mar 29, 2021
$5.5M round with participation from Y Combinator.
For institutional investors. Book with your work email.
ResistanceBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ResistanceBio's valuation, stock price, and market status.
Is ResistanceBio a public or private company?
ResistanceBio is a private company.
What is the current stock price of ResistanceBio?
ResistanceBio is a private company, so its shares have no public market price. Caplight tracks ResistanceBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ResistanceBio worth (valuation)?
ResistanceBio's valuation is estimated at $2.1M based on funding round data.
Can I buy ResistanceBio stock?
ResistanceBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ResistanceBio's last funding round?
ResistanceBio's most recent funding round was Series A on January 31, 2024.
Who are the main investors in ResistanceBio?
Key investors in ResistanceBio include Y Combinator.
Will ResistanceBio IPO soon?
No public IPO plans have been announced for ResistanceBio.
How can I track ResistanceBio secondary market activity?
Caplight tracks bids, offers, and trades in ResistanceBio's shares on secondary markets.